XML 13 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Statements of Stockholders Equity/(Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2022 $ 4,061 $ 5 $ 352,828 $ (348,823) $ 51
Balance (in shares) at Dec. 31, 2022   48,063,358      
Increase (Decrease) in Stockholders' Equity          
Restricted Stock Units released for common stock issued under Equity Incentive Plan (in shares)   50,203      
Stock-based compensation expense 2,055   2,055    
Net Income (Loss) (10,137)     (10,137)  
Other comprehensive loss (51)       (51)
Balance at Mar. 31, 2023 (4,072) $ 5 354,883 (358,960)  
Balance (in shares) at Mar. 31, 2023   48,113,561      
Balance at Dec. 31, 2022 4,061 $ 5 352,828 (348,823) $ 51
Balance (in shares) at Dec. 31, 2022   48,063,358      
Increase (Decrease) in Stockholders' Equity          
Net Income (Loss) (82,084)        
Balance at Sep. 30, 2023 (11,044) $ 7 419,856 (430,907)  
Balance (in shares) at Sep. 30, 2023   77,133,516      
Balance at Mar. 31, 2023 (4,072) $ 5 354,883 (358,960)  
Balance (in shares) at Mar. 31, 2023   48,113,561      
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock and pre-funded warrants, net of issuance costs 27,450 $ 1 27,449    
Issuance of common stock and pre-funded warrants, net of issuance costs (in shares)   9,735,731      
Exercise of pre-funded warrants (in shares)   4,250,000      
Exercise of stock options 22   22    
Exercise of stock options (in shares)   20,174      
Stock-based compensation expense 1,843   1,843    
Net Income (Loss) (29,577)     (29,577)  
Balance at Jun. 30, 2023 (4,334) $ 6 384,197 (388,537)  
Balance (in shares) at Jun. 30, 2023   62,119,466      
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock, net of issuance costs 7,004   7,004    
Issuance of common stock, net of issuance costs (in shares)   4,284,344      
Exercise of common warrants 26,755 $ 1 26,754    
Exercise of common warrants (in shares)   10,250,000      
Exercise of stock options 65   65    
Exercise of stock options (in shares)   65,445      
Exercise of stock options, not yet issued (in shares)   (3,804)      
Restricted Stock Units released for common stock issued under Equity Incentive Plan (in shares)   418,065      
Stock-based compensation expense 1,836   1,836    
Net Income (Loss) (42,370)     (42,370)  
Balance at Sep. 30, 2023 (11,044) $ 7 419,856 (430,907)  
Balance (in shares) at Sep. 30, 2023   77,133,516      
Balance at Dec. 31, 2023 (17,146) $ 8 451,432 (468,586)  
Balance (in shares) at Dec. 31, 2023   84,869,832      
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock and pre-funded warrants, net of issuance costs 104,748 $ 2 104,746    
Issuance of common stock and pre-funded warrants, net of issuance costs (in shares)   15,285,714      
Exercise of common warrants 61,218 $ 1 61,217    
Exercise of common warrants (in shares)   9,025,000      
Exercise of pre-funded warrants (in shares)   4,206,285      
Exercise of stock options 33   33    
Exercise of stock options (in shares)   32,290      
Restricted Stock Units released for common stock issued under Equity Incentive Plan (in shares)   822,682      
Stock-based compensation expense 2,379   2,379    
Net Income (Loss) (83,938)     (83,938)  
Balance at Mar. 31, 2024 67,294 $ 11 619,807 (552,524)  
Balance (in shares) at Mar. 31, 2024   114,241,803      
Balance at Dec. 31, 2023 $ (17,146) $ 8 451,432 (468,586)  
Balance (in shares) at Dec. 31, 2023   84,869,832      
Increase (Decrease) in Stockholders' Equity          
Exercise of stock options (in shares) 327,492        
Net Income (Loss) $ (149,631)        
Balance at Sep. 30, 2024 5,892 $ 11 624,098 (618,217)  
Balance (in shares) at Sep. 30, 2024   116,356,474      
Balance at Mar. 31, 2024 67,294 $ 11 619,807 (552,524)  
Balance (in shares) at Mar. 31, 2024   114,241,803      
Increase (Decrease) in Stockholders' Equity          
Exercise of stock options 310   310    
Exercise of stock options (in shares)   295,202      
Restricted Stock Units released for common stock issued under Equity Incentive Plan (in shares)   309,266      
Stock-based compensation expense 1,890   1,890    
Net Income (Loss) 2,898     2,898  
Balance at Jun. 30, 2024 72,392 $ 11 622,007 (549,626)  
Balance (in shares) at Jun. 30, 2024   114,846,271      
Increase (Decrease) in Stockholders' Equity          
Exercise of pre-funded warrants (in shares)   1,385,525      
Restricted Stock Units released for common stock issued under Equity Incentive Plan (in shares)   124,678      
Stock-based compensation expense 2,091   2,091    
Net Income (Loss) (68,591)     (68,591)  
Balance at Sep. 30, 2024 $ 5,892 $ 11 $ 624,098 $ (618,217)  
Balance (in shares) at Sep. 30, 2024   116,356,474